These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18822712)

  • 1. [Capecitabine in colorectal carcinoma: news from ASCO 2008]].
    Longo F; Mansueto G
    Tumori; 2008; 94(4):suppl 15-23. PubMed ID: 18822712
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on capecitabine alone and in combination regimens in colorectal cancer patients.
    Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On prejudice and facts and choices.
    Köhne CH; Folprecht G
    Ann Oncol; 2006 Feb; 17(2):185-7. PubMed ID: 16428244
    [No Abstract]   [Full Text] [Related]  

  • 4. [ASCO Annual Meeting 2004, New Orleans. Capecitabine in adjuvant therapy of colorectal carcinoma: first... the evidence].
    Longo F; Mansueto G
    Tumori; 2004; 90(5):14-21. PubMed ID: 15656348
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral versus intravenous fluoropyrimidines for advanced colorectal cancer: by either route, it's all the same.
    Mayer RJ
    J Clin Oncol; 2001 Nov; 19(21):4093-6. PubMed ID: 11689576
    [No Abstract]   [Full Text] [Related]  

  • 6. On 5-fluorouracil therapy of colorectal cancer.
    Jensen SA
    Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Capecitabine in the treatment of colorectal cancer].
    Zeuli M; Pino MS; Cognetti F
    Tumori; 2001; 87(1 Suppl 1):S55-6. PubMed ID: 11300027
    [No Abstract]   [Full Text] [Related]  

  • 8. Nursing considerations for capecitabine-based combination therapy.
    Becze E
    ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236
    [No Abstract]   [Full Text] [Related]  

  • 9. X-ACT: an important step on an unfinished journey.
    Maughan T
    Ann Oncol; 2012 Jul; 23(7):1655-8. PubMed ID: 22517823
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis.
    Stec R; Bodnar L; Szczylik C
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):283-92. PubMed ID: 19693536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.
    Santini D; Vincenzi B; Schiavon G; Di Seri M; Virzí V; Spalletta B; Caricato M; Coppola R; Tonini G
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):613-20. PubMed ID: 16944151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
    Punt CJ; Koopman M
    J Clin Oncol; 2008 Apr; 26(11):1907-8; author reply 1908-9. PubMed ID: 18398161
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prevention of diarrhea while under capecitabine therapy].
    Grouls V
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
    [No Abstract]   [Full Text] [Related]  

  • 14. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
    Iqbal S; Lenz HJ
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel methods of treatment for colorectal carcinoma: from oral chemotherapy to angiogenesis inhibitors].
    Longo F; Mansueto G
    Tumori; 2006; 92(1):suppl 1-15. PubMed ID: 16683391
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in efficacy and safety between capecitabine and infusional 5-fluorouracil when combined with irinotecan for the treatment of metastatic colorectal cancer.
    Montagnani F; Chiriatti A; Licitra S; Aliberti C; Fiorentini G
    Clin Colorectal Cancer; 2010 Oct; 9(4):243-7. PubMed ID: 20920997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-modified XELIRI chemotherapy for metastatic colorectal cancer--a retrospective study of 78 patients.
    Tarver K; Conibear J; Raouf S
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):453-4. PubMed ID: 22472457
    [No Abstract]   [Full Text] [Related]  

  • 18. Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison.
    Saif MW
    Clin Colorectal Cancer; 2005 Jul; 5(2):89-100. PubMed ID: 16098249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
    Aprile G; Mazzer M; Moroso S; Puglisi F
    Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of capecitabine in the treatment of colorectal cancer in the elderly.
    Pasetto LM; Monfardini S
    Anticancer Res; 2006; 26(3B):2381-6. PubMed ID: 16821620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.